creatine kinase ck formerly known creatine phosphokinase intracellular enzyme present greatest amounts skeletal muscle myocardium brain smaller amounts occur visceral tissues
disruption cell membranes due hypoxia injury releases ck cellular cytosol systemic circulation
basis elevated serum levels ck used sensitive nonspecific test myocardial infarction
poor specificity reflects ubiquity ck many tissues myocardium
many current assay methods use standard reference value serum ck
normal values best determined locally based method employed ranges healthy controls
values expressed international units per liter
ck dimeric molecule composed two subunits designated b
combinations subunits form isoenzymes ck mm ck mb ck bb
significant concentration ck mb isoenzyme found almost exclusively myocardium appearance elevated ck mb levels serum highly specific sensitive myocardial cell wall injury
normal reference values serum ck mb range percentage total ck iul
ck catalyzes reversible reaction
transferring phosphate groups
common method measuring total ck level involves spectrophotometric determination rate foregoing reaction
results vary widely differing analytical methodology also differences due age sex race level physical activity
separation ck isoenzymes may accomplished electrophoresis column chromatography radioimmunoassay
clinical laboratories use electrophoresis agarose gel cellulose acetate combined band quantification fluorometric spectrophotometric techniques
quantification may also accomplished elution electrophoretic bands
electrophoretically ck bb mobile ck mb intermediate ck mm neutral
although electrophoresis possibly less sensitive column chromatography radioimmunoassay extensive experience adequate routine clinical use
sensitive column chromatography method finds use research applications
radioimmunoassay methods isoenzymes accomplished rapidly may method future development
advent enzymology tool diagnosis myocardial infarction may credited karmen associates documented elevation aspartate aminotransferase ast sgot lactic dehydrogenase ldh serum patients acute myocardial infarction
subsequently search enzyme methods readily performed clinical laboratory permit accurate early sensitive specific diagnosis myocardial infarction
ck mb detection quantification fill role
stated previously determination total ck levels suffers lack specificity
trauma surgery vascular disease metabolic disease central nervous system may produce significant elevation ck
similarly several diseases muscle e g trauma metabolic disease myxedema diabetic ketoacidosis hypothermia inflammatory disease polymyositis degenerative disease duchenne muscular dystrophy may elevate ck levels
particular note elevation ck intramuscular injections often given chest pain
subjected electrophoresis serum healthy individuals contains predominately ck mm isoenzyme
sensitive methodology detect traces ck mb ck bb
major locus ck mb myocardium
exact amounts disputed ranging ck mb ck mm
older reports indicated ck mb absent skeletal muscle radioimmunoassay enzyme analysis reports levels ck mb skeletal muscle
finding may account abnormal levels ck mb reported endurance contact athletes
sources significant ck mb levels rare
process disrupts cardiac sarcolemmal membranes e g myocarditis cardiac trauma cardiac surgery including endomyocardial biopsy release cytosolic ck mb
elevated serum levels ck mb therefore specific myocardial cellular injury acute myocardial infarction
following onset symptoms myocardial infarction ck ck mb increase serum within hours peak levels occur hours
significantly ck mb disappears serum rapid rate ck
example ck mb returns normal hours whereas elevated ck levels may detected hours
window dictates ck ck mb must determined soon possible onset symptoms repeated several times first hours
peak ck mb levels range total ck postinfarction
infarct size may estimated constructing time activity curve appearance peak disappearance ck andor ck mb activity use mathematical model roberts henry sobel
validity method confirmed demonstrating congruence anatomical infarct size estimated value
methodology use interventional studies infarct size reduction widely employed clinically
estimated infarct size independent predictor mortality following acute myocardial infarction
ck enters vascular space via cardiac venous lymphatic drainage following disruption cell membranes
direct entrance ventricular cavity may occur earlier ck rises reported non q wave infarction versus transmural infarction
removal blood pool believed reticuloendothelial system may explain ability drugs increase ck levels prolonging ck half life
following thrombolytic therapy peak release ck ck mb occurs several hours earlier larger amounts given infarct size opposed patients treated conventionally
phenomenon thought result enzyme washout reperfusion
used noninvasive marker reperfusion following intravenous thrombolysis
using prolonged electrophoresis special focusing techniques three subbands ck mm demonstrated man animal models following acute mi
termed ck mm ck mm ck mm
significant amounts ck mm present myocardium released plasma converted ck mm intermediate step ck mm
following myocardial infarction ck mm rises rapidly plasma exceeds ck mm normally dominant plasma subform
experimental mi ck mm rose early hour post mi peaked hours disappeared hours
since ck mm present skeletal muscle test may suffer lack specificity ck levels
appropriate clinical setting however test may allow early diagnosis myocardial infarction infarct extension
study necessary demonstrate clinical utility
early accurate diagnosis acute myocardial infarction obviously desirable goal assessment symptoms planning therapy
additionally expensive coronary care unit time utilized cost effective manner
chest pain syndromes specific absolute ecg diagnosis q wave infarction specific insensitive
determination ck mb isoenzyme predictive value myocardial necrosis positive enzyme profile negative predictive value absence necrosis normal profile
values must assessed within hours symptom onset however
optimal clinical use ck mb determinations following suggestions made
clinician must access quality controlled laboratory capable determining ck ck mb isoenzymes rapidly acceptable degree reproducibility
short serum half life ck mb blood sampling must begin within hours preferably within hours symptoms
serum sampling obtained first contact hour intervals hours observe characteristic appearance peak disappearance ck mb
serial sampling emphasized single values emergency room setting inadequate exclude myocardial injury
patients seen hours symptoms determination lactic dehydrogenase ldh total isoenzymes seeking characteristic elevation total ldh isoenzyme flip seen infarction ldh isoenzyme ldh isoenzyme ratio
presence increased total ldh levels
peak ldh values occur hours following infarction remain abnormal days
false positives uncommon measurement ldh isoenzymes
major pitfalls include hemolysis blood sample hepatic congestion due chf skeletal muscle damage
clinical judgment must exercised rare instance ck mb elevated absence myocardial necrosis
prime example occurrence chest pain athlete competition ck mb levels may elevated percentages absolute values skeletal muscle sources
diagnosis acute mi strongly entertained ck mb levels determined spite normal ck levels
small infarctions may release significant levels ck mb normal total ck
situation unusual however samples obtained analyzed
rapid rise fall ck mb levels myocardial infarction useful sample ck mb hour intervals following recurrent post mi chest pain order detect infarct extension
regardless sensitivity specificity ck mb detecting myocardial injury study diagnostic power diagnosis severe ischemia without infarction
clinical acumen appropriate studies necessary accurate diagnosis